Andrea Burnett-Hartman

Affiliate Instructor, Epidemiology



PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Michigan, 2002
BPH Microbiology & Ecology, Miami University (Ohio), 2000



Kaiser Permanente
Seattle, WA
View Website »

Research Interests

Dr. Burnett-Hartman's research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Colorectal Working Group and a KL2 Scholar at the University of Washington's Institute of Translational Health Sciences (ITHS). In collaboration with the ITHS biomedical informatics and research coordinator cores, Dr. Burnett-Hartman is working to develop, and test, protocols for using biomedical informatics to extract data from electronic medical records.

Recent Publications (PubMed)

Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.
(2022 Sep 27)
Ann Intern Med
Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Lafata JE, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN

Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose CT Screening.
(2022 Aug 29)
J Thorac Oncol
Vachani A, Carroll NM, Simoff MJ, Neslund-Dudas C, Honda S, Greenlee RT, Rendle KA, Burnett-Hartman A, Ritzwoller DP

Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival.
(2022 Aug 17)
Pai RK, Banerjee I, Shivji S, Jain S, Hartman D, Buchanan DD, Jenkins MA, Schaeffer DF, Rosty C, Como J, Phipps AI, Newcomb PA, Burnett-Hartman AN, Le Marchand L, Samadder NJ, Patel B, Swallow C, Lindor NM, Gallinger SJ, Grant RC, Westerling-Bui T, Conner J, Cyr DP, Kirsch R, Pai RK

Social risk factors among individuals with a history of cancer during the COVID-19 pandemic.
(2022 Aug 3)
J Cancer Surviv
Kelly C, White LL, Scott SG, Feigelson HS, Burnett-Hartman AN

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
(2022 Aug 2)
Cancer Epidemiol Biomarkers Prev 31(8): 1521-1531
Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP

Show complete publication list

In the News

No news articles at this time.